This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Micha A Häuptle: Innovator in Polysaccharide Research
Introduction
Micha A Häuptle is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biochemistry, particularly in the development of polysaccharides and their applications in pharmaceuticals.
Latest Patents
Häuptle holds a patent for a polysaccharide known as O25B. This invention includes prokaryotic host cells that contain enzymes, such as glycosyltransferases, which are utilized in the production of O25B. The patent also describes bioconjugates that link O25B to carrier proteins. These compositions, including pharmaceutical formulations, can be used as vaccines against infections caused by ExPEC and may incorporate additional bioconjugates.
Career Highlights
Micha A Häuptle is associated with GlaxoSmithKline Biologicals SA, where she continues to advance her research in polysaccharide applications. Her work has been instrumental in developing innovative solutions for vaccine production.
Collaborations
Häuptle collaborates with notable colleagues, including Michael T Kowarik and Michael L Wetter, contributing to a dynamic research environment focused on bioconjugate technology.
Conclusion
Micha A Häuptle's innovative work in polysaccharide research exemplifies the intersection of science and practical applications in medicine. Her contributions are paving the way for advancements in vaccine development and bioconjugate technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile